EMEA-000236-PIP04-14
Key facts
| Invented name |
Eylea
|
| Active substance |
aflibercept
|
| Therapeutic area |
Ophthalmology
|
| Decision number |
P/0165/2014
|
| PIP number |
EMEA-000236-PIP04-14
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Solution for injection
|
| Contact for public enquiries |
Bayer Pharma AG
Tel. +49 3046 815333 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|